FDA Approved: HORIZANT — Original Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))

View source ↗

Summary

FDA approved Horizant (gabapentin enacarbil) under an original application for the treatment of restless legs syndrome in adults and postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia
• Restless Legs Syndrome

Drugs mentioned

• Horizant (gabapentin enacarbil)

Snippet

ORIG AP for HORIZANT (GABAPENTIN ENACARBIL)